Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7JXT

Ovine COX-1 in complex with the subtype-selective derivative 2a

Summary for 7JXT
Entry DOI10.2210/pdb7jxt/pdb
DescriptorProstaglandin G/H synthase 1, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, PROTOPORPHYRIN IX CONTAINING FE, ... (4 entities in total)
Functional Keywordscyclooxygenase-1, oxidoreductase inhibitor, oxidoreductase, oxidoreductase-inhibitor complex, oxidoreductase/inhibitor
Biological sourceOvis aries (Sheep)
Total number of polymer chains2
Total formula weight132390.55
Authors
Ko, Y.,Iaselli, M.,Miciaccia, M.,Friedrich, L.,Schneider, G.,Scilimati, A.,Cingolani, G. (deposition date: 2020-08-27, release date: 2021-09-01, Last modification date: 2024-10-30)
Primary citationFriedrich, L.,Cingolani, G.,Ko, Y.H.,Iaselli, M.,Miciaccia, M.,Perrone, M.G.,Neukirch, K.,Bobinger, V.,Merk, D.,Hofstetter, R.K.,Werz, O.,Koeberle, A.,Scilimati, A.,Schneider, G.
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design.
Adv Sci, 8:e2100832-e2100832, 2021
Cited by
PubMed Abstract: The repertoire of natural products offers tremendous opportunities for chemical biology and drug discovery. Natural product-inspired synthetic molecules represent an ecologically and economically sustainable alternative to the direct utilization of natural products. De novo design with machine intelligence bridges the gap between the worlds of bioactive natural products and synthetic molecules. On employing the compound Marinopyrrole A from marine Streptomyces as a design template, the algorithm constructs innovative small molecules that can be synthesized in three steps, following the computationally suggested synthesis route. Computational activity prediction reveals cyclooxygenase (COX) as a putative target of both Marinopyrrole A and the de novo designs. The molecular designs are experimentally confirmed as selective COX-1 inhibitors with nanomolar potency. X-ray structure analysis reveals the binding of the most selective compound to COX-1. This molecular design approach provides a blueprint for natural product-inspired hit and lead identification for drug discovery with machine intelligence.
PubMed: 34176236
DOI: 10.1002/advs.202100832
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.35 Å)
Structure validation

248942

PDB entries from 2026-02-11

PDB statisticsPDBj update infoContact PDBjnumon